Cadila Healthcare informs about press release

21 Jul 2021 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated July 21, 2021 titled ‘European Medicines Agency grants Orphan Drug Designation to Saroglitazar Mg for the treatment of patients with Primary Biliary Cholangitis (PBC)’. Bring this news to the notice of the members of the exchange and the investors’ at large.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

884.65 -11.95 (-1.33%)
29-Jan-2026 09:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1199.20
Cipla 1311.90
Zydus Lifesciences 884.65
Lupin 2104.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×